Method of preventing or alleviating mammalian obesity
US6033656A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | May 4, 1999 |
| Grant date | Mar 7, 2000 |
| Priority date | — |
| Expiry date | May 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/336
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of suppressing the activation of Peroxisome Proliferator-Activated Receptor gamma in a mammalian body by administering an effective amount of bisphenol A diglycidyl ether to a mammal, methods of suppressing the accumulation of fat in the mammalian fat cell or adipose tissue by administering an effective amount of bisphenol A diglycidyl ether to a mammal, methods of preventing or alleviating mammalian obesity by administering an effective amount of bisphenol A diglycidyl ether to a mammal, bisphenol A diglycidyl ether for use as an active pharmaceutical substance or composition for the treatment of obesity, and uses of bisphenol A diglycidyl either for the preparation of a pharmaceutical composition for the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.